Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-29 @ 1:45 PM
Study NCT ID:
NCT01380808
Status:
COMPLETED
Last Update Posted:
2013-07-26
First Post:
2011-05-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)
Sponsor:
Fudan University
Organization:
Study Overview
Official Title:
A Phase II Study of Capecitabine and Pseudomonas Aeruginosa Combination in the Salvage Treatment of Metastatic Breast Cancer
Status:
COMPLETED
Status Verified Date:
2013-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The progression free survival could be prolonged adding pseudomonas aeruginosa to monotherapy capecitabine.
Detailed Description:
the efficacy of the combination is much better than monotherapy
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: